Trial Profile
A phase 2 clinical trial of Dovitinib for breast cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2018
Price :
$35
*
At a glance
- Drugs Dovitinib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 14 Sep 2018 New trial record